Drug Database
SU

sumatriptan succinate (Zelrix / NP101 / Zecuity)

✓ Approved

Nupathe Inc. · HTR1D · Small Molecule

What is sumatriptan succinate?

sumatriptan succinate is a small molecule developed by Nupathe Inc.. It is approved for therapeutic indications via topical or transdermal.

Drug Profile

Brand NamesZelrix, NP101, Zecuity
CompanyNupathe Inc.
Drug ClassSmall Molecule
Molecular TargetHTR1D
RouteTopical, Transdermal
StatusApproved

Mechanism of Action

Molecular Targets

sumatriptan succinate acts on 1 molecular target:

HTR1D5-hydroxytryptamine receptor 1D (HTR1DA, HT1DA)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

sumatriptan succinate is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Nervous system disordersMigraine✓ Approved

Related Research Articles

PubMedJournal of the American Chemical Society2026-05-24

How Fe(II)/2-Oxoglutarate Oxygenase Chooses Chlorination over Hydroxylation: Electric Field-Driven Ligand Exchange Governs C-Cl Formation.

Jaber Sathik Rifayee Simahudeen Bathir SB, Thomas Midhun George MG, Krishnan Anandhu A, Gupta Kritika K et al.

Non-heme Fe(II)/2-oxoglutarate (2OG)-dependent halogenases catalyze highly selective C-H halogenation. BesD is a non-heme Fe(II)/2OG halogenase that performs regio- and stereoselective chlorination of the l-lysine (l-Lys) substrate. Understanding the mechanism by which halogenation is favored over canonical hydroxylation is essential for guiding enzyme engineering efforts aimed at converting hydroxylases into halogenases. Here, we combine molecular dynamics (MD) and hybrid quantum mechanics/molecular mechanics (QM/MM) calculations to elucidate the origin of chlorination selectivity in BesD and variants derived from a homologous hydroxylase. Our results indicate that, although the initial inline Cl-Fe(III)-OH intermediate is inherently predisposed toward hydroxylation, it undergoes a two-step isomerization in which the -Cl and -OH ligands exchange coordination positions. This rearrangement positions the chloride ligand trans to H207, where the protein's intrinsic electric field (IEF) enhances Fe-Cl bond polarization and promotes C-Cl bond formation, ultimately enabling the selective chlorination of l-Lys. Comparative analysis of the homologous hydroxylase and two halogenation-competent variants (Hydrox-3R and Chimera14) reveals halogenase-specific correlated motions between substituted second coordination sphere, long-range residues with the active-site, particularly the coordinated succinate, and the substrate. Notably, these collective motions mirror those observed in the native halogenase BesD. Furthermore, the Hydrox-3R and Chimera14 variants employ a two-step isomerization strategy analogous to that of BesD, enabling efficient chlorination through IEF alignment along the Fe-Cl bond. These results highlight the critical roles of collective correlated motions, the second coordination sphere, and long-range interactions, as well as enzyme-generated electric fields, in determining halogenation selectivity in non-heme Fe(II)/2OG-dependent oxygenases. Ultimately, halogenation is achieved not due to a new catalytic mechanism, but rather due to subtle electronic, geometric, and dynamic perturbations of a hydroxylase scaffold. These insights provide a mechanistic framework for engineering hydroxylases into halogenases with enhanced activity.

PubMedMicrobial biotechnology2026-05-22

A Stereospecific Lactic Acid Exclusion Biosensor for Grass Silage Fed Green Biorefinery.

van Roosmalen Roderick N RN, Murphy Cormac D CD, Sweeney Joseph B JB

Grass silage fed green biorefineries require high quality grass silage leachates to produce high quality products. Real-time, cost-effective methods to monitor key leachate analytes are needed for small-scale decentralised systems. In this study, Escherichia coli mutants, designated JSP0090 and JSP0094, were created to quantify d- and l-lactic acid concentrations in grass leachate samples using an oxygen probe. The genes encoding either d- or l-lactate dehydrogenase were expressed in an exclusion biosensor strain (JSK0115). This strain required successive gene deletions to prevent interference from sugars, amino acids and organic acids present in grass silage leachates. This strain was incapable of catabolising d-lactic acid, l-lactic acid, acetic acid, propionic acid, formic acid, ethanol, glucose, fructose, l-alanine, VFAs, glycerol, mannitol and succinate. Gene knockouts were achieved using P1 phage lysates and CRISPR Cas 9 methods to target key steps in the catabolism of these compounds, with the exception of succinate. For this metabolite, the di-carboxylic acid transporters YaaH, DctA, YchM, DcuA and DcuB had to be deleted. The effectiveness of the biosensors for selectively measuring d- and l-lactic acid was assessed in Austrian and Irish grass silage leachate. The concentrations measured were comparable to those obtained using a commercial enzyme kit.

PubMedRevue neurologique2026-05-22

Real-world utilization of acute treatments for cluster headache: Insights from the French National Open Health Data.

Arcani V V, Bruyat A A, Hache G G, Donnet A A et al.

The utilization of open health databases offers a unique opportunity to analyze the dispensing of healthcare products within real-world populations. A recent study by Van Obberghen et al. (2025) was the first to leverage the French national database to examine consumption volumes for cluster headache (CH) treatments, with a specific focus on the sex ratio. Nonetheless, further investigation into additional variables - such as seasonality and geographical distribution - is warranted, given the well-established role of chronobiology in the pathophysiology of CH. The primary objective of this study was to characterize the clinical expression of CH using real-world healthcare data, specifically assessing the influence of gender, age, and temporal-spatial factors. Additionally, we aimed to quantify the evolving economic burden of CH treatments at the national level. A retrospective analysis was conducted using the French national health database (2014-2024). We extracted dispensing records for subcutaneous sumatriptan (SS) and oxygen therapy (OT), the two validated acute treatments for CH. These patterns were analyzed across demographic groups and administrative regions, with statistical correlations performed against climatic (sunshine, rainfall), demographic, and economic variables. Between 2014 and 2024, the total expenditure for OT in CH tripled, while SS costs increased only 1.6-fold. A consistent decrease in the male-to-female sex ratio was observed across all age groups for both treatments. This decline was statistically significant in all three age groups over 20 years of age for OT delivery, and in the two age groups between 20 and 59 years for SS delivery. A distinct peak in SS dispensing was observed in July; however, no statistically significant associations were found between SS dispensing and sunshine or rainfall. Younger men exhibited significantly higher consumption than older men, and overall consumption remained higher in men than in women. Our findings highlight evolving treatment patterns and a shifting sex ratio in the delivery of CH therapies among treated patients. While no clear environmental drivers of treatment use were identified, the study underscores the value of open health data in monitoring prescribing trends and evaluating the economic impact of CH therapies.

PubMedBMC microbiology2026-05-22

Antibacterial mechanism and in vivo efficacy of cladribine against carbapenem-resistant Klebsiella pneumoniae.

Liu Kai-Di KD, Wang Fan-Yue FY, Liu Jun-Qi JQ, Hao Wei-Hua WH et al.

The proliferation and dissemination of carbapenem-resistant Klebsiella pneumoniae (CRKP) constitutes a critical public health concern, underscoring the urgent need for novel antimicrobial agents. In this study, we identified cladribine, a synthetic purine analogue, as a potential antimicrobial candidate against CRKP. Cladribine exhibited an MIC of 64 μg/mL against clinical CRKP isolates. Consistently, growth curve and time-kill assays also demonstrated that cladribine displays measurable inhibitory and bactericidal effects against CRKP, achieving a 4 log10 CFU reduction. Mechanistically, cladribine increased bacterial membrane permeability and induced oxidative stress, as evidenced by elevated intracellular reactive oxygen species (ROS) and malondialdehyde (MDA) levels, accompanied by the activation of oxidative stress-related genes. Cladribine also impaired bacterial energy metabolism, resulting in reduced succinate dehydrogenase (SDH) and pyruvate kinase (PK) activities and decreased ATP levels. In a mouse lung infection model, treatment with 10 mg/kg and 20 mg/kg cladribine significantly reduced pulmonary bacterial burden by approximately by 2.0 log10 CFU and 3.0 log10 CFU, respectively. In addition, cladribine alleviated CRKP-induced lung injury, and suppressed the transcription of pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6, indicating both antibacterial and anti-inflammatory effects in vivo. These findings suggest that cladribine has potential as a therapeutic candidate against CRKP infection and provide preliminary mechanistic insights that may contribute to a better understanding of its antibacterial activity.

PubMedJournal of hazardous materials2026-05-22

Mechanistic insights into the molecular selectivity and cotransport dynamics of biodegradable microplastic-derived DOM with cadmium in saturated porous media.

Liu Kang K, Liu Chao C, Zhang Wu W, Zong Chengyuan C et al.

The widespread use of biodegradable plastics (BDPs) results in the release of biodegradable microplastics-derived dissolved organic matter (BMP-DOM) during environmental weathering. The role of its molecular characteristics in regulating the subsurface transport of coexisting heavy metals, however, remains unclear. Here we investigated the cotransport of cadmium (Cd) with DOM derived from three representative BDPs (polybutylene adipate terephthalate, PBAT; polybutylene succinate, PBS; and polylactide, PLA) at two aging stages in saturated porous media. Molecular characterization revealed clear polymer-dependent signatures. PBAT-DOM was distinctively enriched in aromatic structures and lignin-like compounds, while PBS-DOM featured a prominent aliphatic/peptide-like signature, and PLA-DOM was characterized by a unique carboxylic-rich nature and high O/C ratio. FT-ICR MS analysis of the acid-stable fraction revealed a strong affinity of Cd for condensed and unsaturated molecules; however, these stable complexes showed no clear correlation with macroscopic transport behavior. Column experiments demonstrated that all BMP-DOM types enhanced Cd mobility and increased recovery by 4.5-26.6%. This enhancement was concentration dependent. Molecular composition dominated transport efficiency at low concentrations (1.5 mg C/L), whereas DOM abundance and surface site saturation dominated at higher concentrations (15 mg C/L). Furthermore, Cd transport was mainly facilitated by acid-labile DOM fractions that are often overlooked by conventional solid-phase extraction. These results demonstrate that Cd transport potential is jointly controlled by polymer type and aging stage through their influence on reactive ligand generation. This study highlights the importance of BMP-DOM chemistry in regulating metal mobility and provides a molecular basis for environmental risk assessment.

PubMedCryobiology2026-05-22

Protective effects of melatonin on mouse ovarian tissue against oxidative stress and ferroptosis may involve the MT1 receptor.

Jiang Sheng Nan SN, Zhang Xin X, Si Li Na LN, Wei Meng M et al.

Ovarian cryopreservation is an important method for fertility preservation, with oxidative stress and ferroptosis being key contributors to cryopreservation-induced ovarian damage. Previous studies have shown that melatonin (MLT) protects vitrified-warmed mouse ovarian tissues (OTs), but the underlying mechanism remains unclear. This study investigated whether MLT inhibits oxidative stress and ferroptosis via MT1/MT2 receptors. The cryopreservation/thawing medium was supplemented with 0 mM MLT, 0.1 mM MLT, 0.1 mM MLT + Luzindole (a non-selective MT1/MT2 antagonist), or 0.1 mM MLT + 4P-PDOT (a selective MT2 antagonist). Mitochondrial morphology and function were assessed by transmission electron microscopy (TEM), ATP levels, succinate dehydrogenase (SDH) activity, and 8-hydroxy-2'-deoxyguanosine (8-OHdG) content. MLT receptor expression was analyzed by Western blotting. Following antagonist treatment, follicular morphology was examined by H&E staining, ovarian reserve by Anti-Müllerian Hormone (AMH) immunohistochemistry (IHC), and apoptosis by Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Oxidative stress markers (T-SOD, GSH, LPO, Fe2+) and key proteins Phosphatidylinositol 3-Kinase (PI3K), Protein Kinase B (AKT), Phosphorylated Protein Kinase B (P-AKT), Nuclear factor erythroid 2-related factor 2 (Nrf2), Solute Carrier Family 7 Member 11 (SLC7A11/xCT), Glutathione Peroxidase 4 (GPX4), Ferritin Heavy Chain 1 (FTH1), Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4) were measured. Compared to the no-MLT group, the MLT group exhibited improved mitochondrial morphology, increased ATP and SDH levels, and reduced 8-OHdG. MLT and MLT+4P-PDOT groups maintained follicular structure, enhanced ovarian reserve, elevated T-SOD and GSH levels, decreased LPO and Fe2+, and showed reduced apoptosis, along with upregulated PI3K, P-AKT/AKT, Nrf2, xCT, GPX4, and FTH1 expression and downregulated ACSL4. In contrast, MLT + Luzindole reversed these effects. Therefore, our findings suggest that MLT alleviates oxidative stress and preserves mitochondrial morphology and function in cryopreserved mouse ovarian tissues. The underlying mechanisms may mainly involve MT1 receptor-associated modulation of the PI3K/AKT/Nrf2/xCT/GPX4 signaling pathway, which could contribute to the attenuation of oxidative stress and ferroptosis.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about sumatriptan succinate